Loading clinical trials...
Loading clinical trials...
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
The aims of this study are: 1. to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out); 2. to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction). Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and 3. to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics). Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.
Age
18 - 100 years
Sex
ALL
Healthy Volunteers
Yes
Providence St. Joseph Health (Data Collection Only)
Irvine, California, United States
BAPTIST ALLIANCE - MCI (Data Collection Only)
Miami, Florida, United States
Advocate Health Care Network
Libertyville, Illinois, United States
University of Kentucky (Data Collection Only)
Lexington, Kentucky, United States
Munson Healthcare (Data Collection Only)
Traverse City, Michigan, United States
Hackensack Meridian Health (Data collection only)
Hackensack, New Jersey, United States
Roswell Park Cancer Institute (Data Collection Only)
Buffalo, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Virtua Health (Data Collection Only)
Philadelphia, Pennsylvania, United States
University of Pennsylvania (Data Collection Only)
Philadelphia, Pennsylvania, United States
Start Date
April 28, 2023
Primary Completion Date
August 31, 2026
Completion Date
August 31, 2026
Last Updated
March 17, 2026
1,232
ESTIMATED participants
Empathic Communication Skills (ECS) training
BEHAVIORAL
Standard of Care participant interaction
OTHER
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT06498635
NCT07336732
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06066138